FdaApplication
ANDA 208272
Identifiers
- fda_app_no: ANDA208272
Properties
| Property | Value |
|---|---|
| applicant_name | TORRENT PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2018-08-06 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ROFLUMILAST | ROFLUMILAST | 250MCG | TABLET;ORAL |
| ROFLUMILAST | ROFLUMILAST | 500MCG | TABLET;ORAL |
2 products